Blair William & Co. IL acquired a new position in Quintiles Transitional Holdings Inc. (NYSE:Q) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,246 shares of the medical research company’s stock, valued at approximately $201,000.

Several other large investors have also modified their holdings of Q. Global X Management Co. LLC lifted its stake in shares of Quintiles Transitional Holdings by 30.8% in the 1st quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock worth $118,000 after purchasing an additional 346 shares during the period. Korea Investment CORP lifted its stake in shares of Quintiles Transitional Holdings by 142.5% in the 2nd quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock worth $123,000 after purchasing an additional 805 shares during the period. IFP Advisors Inc lifted its stake in shares of Quintiles Transitional Holdings by 187.1% in the 1st quarter. IFP Advisors Inc now owns 1,774 shares of the medical research company’s stock worth $143,000 after purchasing an additional 1,156 shares during the period. Archford Capital Strategies LLC bought a new position in shares of Quintiles Transitional Holdings in the 1st quarter worth approximately $160,000. Finally, Bbva Compass Bancshares Inc. bought a new position in shares of Quintiles Transitional Holdings in the 1st quarter worth approximately $170,000. Hedge funds and other institutional investors own 91.36% of the company’s stock.

In other news, insider Kevin C. Knightly sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total transaction of $1,805,600.00. Following the completion of the transaction, the insider now directly owns 46,826 shares of the company’s stock, valued at approximately $4,227,451.28. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Kevin C. Knightly sold 19,339 shares of the company’s stock in a transaction that occurred on Friday, August 25th. The stock was sold at an average price of $99.51, for a total value of $1,924,423.89. Following the transaction, the insider now directly owns 40,650 shares of the company’s stock, valued at $4,045,081.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,363,847 shares of company stock valued at $618,573,696. Corporate insiders own 6.40% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Blair William & Co. IL Invests $201,000 in Quintiles Transitional Holdings Inc. (Q)” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.dailypolitical.com/2017/09/10/blair-william-co-il-invests-201000-in-quintiles-transitional-holdings-inc-q.html.

Shares of Quintiles Transitional Holdings Inc. (Q) opened at 97.00 on Friday. Quintiles Transitional Holdings Inc. has a one year low of $70.10 and a one year high of $99.95. The firm’s 50-day moving average is $92.86 and its 200-day moving average is $85.81. The stock has a market capitalization of $21.00 billion, a price-to-earnings ratio of 281.16 and a beta of 0.63.

Quintiles Transitional Holdings (NYSE:Q) last announced its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.05 by $0.04. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.96 billion. Quintiles Transitional Holdings had a return on equity of 14.23% and a net margin of 0.82%. Quintiles Transitional Holdings’s revenue for the quarter was up 68.7% on a year-over-year basis. During the same period in the previous year, the company posted $0.93 earnings per share. Equities research analysts forecast that Quintiles Transitional Holdings Inc. will post $4.58 EPS for the current year.

Quintiles Transitional Holdings declared that its Board of Directors has authorized a stock buyback program on Wednesday, May 24th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the medical research company to repurchase up to 5.4% of its shares through open market purchases. Shares buyback programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Several equities analysts have recently weighed in on the stock. BidaskClub cut shares of Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research note on Friday, August 11th. Jefferies Group LLC reiterated a “hold” rating and issued a $94.00 price objective on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. William Blair upgraded shares of Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $70.10 to $93.42 in a research note on Friday, August 4th. Citigroup Inc. increased their price objective on shares of Quintiles Transitional Holdings from $96.00 to $97.00 and gave the stock a “neutral” rating in a research note on Monday, August 7th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $92.00 price objective (up previously from $87.00) on shares of Quintiles Transitional Holdings in a research note on Friday, August 4th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $90.25.

Quintiles Transitional Holdings Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Want to see what other hedge funds are holding Q? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quintiles Transitional Holdings Inc. (NYSE:Q).

Institutional Ownership by Quarter for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.